1. Home
  2. DHX vs TTRX Comparison

DHX vs TTRX Comparison

Compare DHX & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$4.03

Market Cap

150.3M

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.62

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
TTRX
Founded
1991
2015
Country
United States
United States
Employees
N/A
2
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
150.3M
281.2M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
DHX
TTRX
Price
$4.03
$9.62
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$6.25
$8.00
AVG Volume (30 Days)
152.0K
86.0K
Earning Date
05-05-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.04
N/A
Revenue
$127,826,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
N/A
P/E Ratio
$99.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$2.57
52 Week High
$4.32
$11.69

Technical Indicators

Market Signals
Indicator
DHX
TTRX
Relative Strength Index (RSI) 61.13 72.73
Support Level $3.49 $4.40
Resistance Level N/A N/A
Average True Range (ATR) 0.26 0.99
MACD 0.02 0.24
Stochastic Oscillator 62.97 63.82

Price Performance

Historical Comparison
DHX
TTRX

About DHX DHI Group Inc.

DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: